ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling Pathways.
Liao X, Qian X, Zhang Z, Tao Y, Li Z, Zhang Q, Liang H, Li X, Xie Y, Zhuo R, Chen Y, Jiang Y, Cao H, Niu J, Xue C, Ni J, Pan J, Cui D.
Liao X, et al. Among authors: qian x.
Front Oncol. 2021 Oct 18;11:753119. doi: 10.3389/fonc.2021.753119. eCollection 2021.
Front Oncol. 2021.
PMID: 34733788
Free PMC article.